Health & Fitness
Health and Fitness
Health and Fitness
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010 Ligand to Report Second Quarter Results on August 5th
SAN DIEGO--([ BUSINESS WIRE ])--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report second quarter 2010 financial results on Thursday, August 5, 2010. Liganda™s President and CEO, John L. Higgins and Vice President of Finance and CFO, John Sharp will host the conference call.
Second Quarter Earnings Call
| What: | Ligand Pharmaceuticals conference call to discuss financial results and provide general business updates. | |||
| When: | Thursday, August 5, 2010 | |||
| Time: | 6:00 a.m. Pacific time (9:00 a.m. Eastern time) | |||
| Webcast: | Conference call and replay accessible at [ www.ligand.com ]. | |||
| Conference Call: | (877) 407-4019, passcode: Ligand | |||
| (201) 689-8337 outside the U.S. | ||||
| Replay: | (877) 660-6853, Account #: 361 passcode: 353874 | |||
| (201) 612-7415 outside the U.S. | ||||
About Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, inflammatory diseases, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based assays, gene-expression tools, ultra-high throughput screening and one of the world's largest combinatorial chemical libraries. Ligand has strategic alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Merck, Pfizer, Roche, Bristol-Myers Squibb, and Cephalon and more than 30 programs are in various stages of development by its partners.
